1. Home
  2. ATNM vs BTOC Comparison

ATNM vs BTOC Comparison

Compare ATNM & BTOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • BTOC
  • Stock Information
  • Founded
  • ATNM 2000
  • BTOC 2020
  • Country
  • ATNM United States
  • BTOC United States
  • Employees
  • ATNM N/A
  • BTOC N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • BTOC
  • Sector
  • ATNM Health Care
  • BTOC
  • Exchange
  • ATNM Nasdaq
  • BTOC Nasdaq
  • Market Cap
  • ATNM 46.5M
  • BTOC 54.6M
  • IPO Year
  • ATNM N/A
  • BTOC 2024
  • Fundamental
  • Price
  • ATNM $1.21
  • BTOC $1.04
  • Analyst Decision
  • ATNM Strong Buy
  • BTOC
  • Analyst Count
  • ATNM 4
  • BTOC 0
  • Target Price
  • ATNM $8.75
  • BTOC N/A
  • AVG Volume (30 Days)
  • ATNM 1.4M
  • BTOC 93.0K
  • Earning Date
  • ATNM 04-29-2025
  • BTOC 02-14-2025
  • Dividend Yield
  • ATNM N/A
  • BTOC N/A
  • EPS Growth
  • ATNM N/A
  • BTOC N/A
  • EPS
  • ATNM N/A
  • BTOC N/A
  • Revenue
  • ATNM N/A
  • BTOC $177,352,684.00
  • Revenue This Year
  • ATNM N/A
  • BTOC $30.78
  • Revenue Next Year
  • ATNM N/A
  • BTOC $17.61
  • P/E Ratio
  • ATNM N/A
  • BTOC N/A
  • Revenue Growth
  • ATNM N/A
  • BTOC 10.30
  • 52 Week Low
  • ATNM $1.03
  • BTOC $0.80
  • 52 Week High
  • ATNM $10.24
  • BTOC $8.74
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 43.76
  • BTOC N/A
  • Support Level
  • ATNM $1.18
  • BTOC N/A
  • Resistance Level
  • ATNM $1.34
  • BTOC N/A
  • Average True Range (ATR)
  • ATNM 0.15
  • BTOC 0.00
  • MACD
  • ATNM -0.03
  • BTOC 0.00
  • Stochastic Oscillator
  • ATNM 11.99
  • BTOC 0.00

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About BTOC Armlogi Holding Corp. Common Stock

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

Share on Social Networks: